4 insiders reported 4 Form 4 transactions for NeuroSense Therapeutics Ltd. (NRSN) over the past 18 months (most recent 2026-06-17). Recent activity: Eisenberg Or (Chief Financial Officer) Buy 250,000 shares, Ben-Noon Alon (Chief Executive Officer) Buy 250,000 shares, Binder Hagit (General Manager) Buy 200,000 shares, Russek-Blum Niva (Chief Technology Officer) Buy 200,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-17 | Eisenberg Or | Chief Financial Officer | Buy | 250,000 | $200,000 |
| 2026-06-17 | Ben-Noon Alon | Chief Executive Officer | Buy | 250,000 | $200,000 |
| 2026-03-30 | Binder Hagit | General Manager | Buy | 200,000 | $0 |
| 2026-03-30 | Russek-Blum Niva | Chief Technology Officer | Buy | 200,000 | $0 |
Source: SEC Form 4 filings · as of 2026-06-17